EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
6.3.2.2 | Acatalasia |
34390818 |
Compromised glutathione synthesis results in high susceptibility to acetaminophen hepatotoxicity in acatalasemic mice. |
causal interaction ongoing research unassigned |
4 2 0 |
6.3.2.2 | Adenocarcinoma |
3945723 |
Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts. |
ongoing research therapeutic application unassigned |
4 1 0 |
6.3.2.2 | Adenocarcinoma |
11925926 |
[Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray] |
diagnostic usage ongoing research unassigned |
3 4 0 |
6.3.2.2 | Adenocarcinoma |
14532974 |
The modifier subunit of glutamate cysteine ligase (GCLM) is a molecular target for amelioration of cisplatin resistance in lung cancer. |
diagnostic usage ongoing research therapeutic application unassigned |
2 4 4 0 |
6.3.2.2 | Adenocarcinoma of Lung |
29474642 |
Glutamate-cysteine ligase catalytic subunit is associated with cisplatin resistance in lung adenocarcinoma. |
causal interaction therapeutic application unassigned |
4 2 0 |
6.3.2.2 | Adenoma |
11774239 |
Expression of heavy subunit of gamma-glutamylcysteine synthetase (gamma-GCSh) in human colorectal carcinoma. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 4 4 1 |
6.3.2.2 | Adenoma |
30841685 |
[The correlation of ganglion cell layer thickness with visual field defect in non-functional pituitary adenoma with chiasm compression]. |
causal interaction therapeutic application unassigned |
2 1 0 |
6.3.2.2 | Ageusia |
33719624 |
Optic nerve and macular optical coherence tomography in recovered COVID-19 patients. |
unassigned |
0 |
6.3.2.2 | Albinism |
32196097 |
Assessing Ganglion Cell Layer Topography in Human Albinism Using Optical Coherence Tomography. |
causal interaction diagnostic usage therapeutic application unassigned |
3 2 1 0 |
6.3.2.2 | Alzheimer Disease |
8725900 |
Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. |
diagnostic usage unassigned |
3 0 |